Exploring the heterogeneity of HER2 gene status and expression in non-positive breast cancer patients: insights from immunohistochemistry and fluorescence in situ hybridization

Related articles

1. [68Ga]Ga-HER2 Affibody PET/CT for early prediction of neoadjuvant therapy outcome in HER2-positive breast cancer

   This article has 14 authors:

   1. Yuhan Sun
   2. Ran An
   3. Ruoxi Yang
   4. Xiao Pang
   5. Xiaoshan Chen
   6. Mengjiao Wang
   7. Jianqiang Zhao
   8. Xiaolin Chen
   9. Qiang Fu
   10. Yunuan Liu
   11. Jingya Han
   12. Na Wang
   13. Yan Zhao
   14. Xinming Zhao

2. Breast cancer immunohistochemical patterns in Morocco: changes suggested by comparison with contemporary data

   This article has 8 authors:

   1. Rim Alami
   2. Reyzane El Mjabber
   3. Fatima-Ezzahra Aouzah
   4. Omar Alami
   5. Reda Alami
   6. Asmaa Naim
   7. Nadia Benchakroun
   8. Abdellatif Benider

3. The Value of LAR in Predicting Neoadjuvant Therapy Response and Prognosis in HER-2-Positive Breast Cancer

   This article has 5 authors:

   1. Xiaojing Li
   2. Xin Xin
   3. Wenjing Xiong
   4. Haoyue zhang
   5. Yue Zhang